Provided by Tiger Fintech (Singapore) Pte. Ltd.

LivaNova PLC

43.67
+0.38000.88%
Post-market: 43.670.00000.00%16:51 EDT
Volume:411.20K
Turnover:17.93M
Market Cap:2.38B
PE:-10.68
High:43.95
Open:43.55
Low:42.86
Close:43.29
Loading ...

Livanova plc to Announce Second-Quarter 2025 Results

Reuters
·
09 Jul

LivaNova to Announce Second-Quarter 2025 Results

THOMSON REUTERS
·
09 Jul

LivaNova (NASDAQ:LIVN) Is Experiencing Growth In Returns On Capital

Simply Wall St.
·
07 Jul

LivaNova plc Conducted Annual General Meeting with Shareholder Votes Cast

Reuters
·
12 Jun

BRIEF-Livanova Announces Core-Vns 24-Month Data Show Adjunctive Vns Therapy Is Associated With Substantial Reductions In Generalized Tonic-Clonic Seizures In People With Drug-Resistant Epilepsy

Reuters
·
05 Jun

LivaNova Announces Core-Vns 24-Month Data Show Adjunctive Vns Therapy Is Associated With Substantial Reductions in Generalized Tonic-Clonic Seizures in People With Drug-Resistant Epilepsy

THOMSON REUTERS
·
05 Jun

LivaNova Plc - 77% Median Seizure Reduction, 43% Seizure Freedom at 24 Months

THOMSON REUTERS
·
05 Jun

LivaNova Plc - 52% Median Seizure Reduction at Three Months

THOMSON REUTERS
·
05 Jun

Barclays Remains a Hold on LivaNova (LIVN)

TIPRANKS
·
05 Jun

LivaNova PLC Seeks Reconsideration of National Coverage for VNS Therapy in Treatment-Resistant Depression from U.S. CMS

Reuters
·
04 Jun

LivaNova Initiates Process With U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for Vns Therapy for Treatment-Resistant Depression

THOMSON REUTERS
·
04 Jun

LivaNova: Continues to Believe Recorded Liability Remains Best Estimate of Liability Associated With Snia Matter - SEC Filing

THOMSON REUTERS
·
22 May

LivaNova Plc: No Adjustments Have Been Made to Accrual or Company's Full-Year 2025 Guidance

THOMSON REUTERS
·
22 May

Italian Ministries Ask for More Fines on LivaNova

Dow Jones
·
22 May

LivaNova PLC Faces Ongoing Legal Battle Over Environmental Liabilities as Italian Supreme Court Refers Case Back to Court of Appeal

Reuters
·
22 May

LivaNova Raised to Outperform From Peer Perform by Wolfe Research

Dow Jones
·
21 May

Wolfe Upgrades LivaNova to Outperform From Peer Perform, Price Target is $60

MT Newswires Live
·
20 May

LivaNova to Present at Jefferies Global Healthcare Conference in New York

Reuters
·
15 May

LivaNova Price Target Maintained With a $64.00/Share by Needham

Dow Jones
·
13 May

LivaNova PLC: Strong Growth Amidst Challenges in Earnings Call

TIPRANKS
·
13 May